WuXi AppTec, a company that provides R&D and manufacturing services, has commissioned two new peptide manufacturing plants, one at its Changzhou facility and another at the new Taixing site in China. The expansion increases the company’s Solid-Phase Peptide Synthesis (SPPS) total reactor volume to 32,000 liters, which aims to address increasing global demand for peptide therapeutics.   Both new peptide plants use digital operation systems with automated solvent delivery, which aims to opti...